首页|帕罗西汀联合米氮平对卒中后抑郁患者认知功能及HAMD评分的影响

帕罗西汀联合米氮平对卒中后抑郁患者认知功能及HAMD评分的影响

扫码查看
目的 探讨卒中后抑郁(PSD)患者采用帕罗西汀联合米氮平对其认知功能及汉密尔顿抑郁量表(HAMD)评分的影响.方法 本研究为一项前瞻性研究,采用随机数表法分为观察组(n=57 例)、对照组(n=56 例).对照组接受帕罗西汀治疗,观察组接受帕罗西汀联合米氮平治疗.两组均持续治疗 6 周,对比两组认知功能[采用威斯康星卡片分类测验(WCST)评估]、HAMD评分及不良反应.结果 治疗后,两组WCST各项评分均改善,观察组各项评分均优于对照组(P<0.05);治疗后,两组HAMD评分均下降,观察组低于对照组(P<0.05);两组不良反应对比(P>0.05).结论 帕罗西汀联合米氮平能够有效改PSD善患者认知功能及抑郁程度.
Effects of Paroxetine Combined with Mirtazapine on Cognitive Function and HAMD Score in Patients with Poststroke Depression
Objective To investigate the effects of paroxetine combined with Mirtazapine on cognitive function and Hamilton Depression Scale(HAMD)score in patients with poststroke depression(PSD).Methods This was a prospective study.113 patients with poststroke depression were enrolled in this study.They were divided into observation group(n=57 cases)and control group(n=56 cases)by random number table.The control group received paroxetine treatment,and the observation group received paroxetine combined with mirtazapine treatment.Cognitive function[as assessed by Wisconsin card Sorting Test(WC-ST)],HAMD score and adverse effects were compared between the two groups.Results After treatment,WCST scores of both groups were improved,and scores of observation group were better than control group(P<0.05).After treatment,HAMD scores in both groups were decreased,and the observation group was lower than the control group(P<0.05).The adverse reactions of the two groups were compared(P>0.05).Conclusion Paroxetine combined with mirtazapine can effectively improve cognitive function and depression in patients with PSD.

stroke depressionParoxetineMirtazapineCognitive functionDegree of depression

孙晓净

展开 >

南阳医学高等专科学校第一附属医院,河南 南阳 473000

卒中抑郁 帕罗西汀 米氮平 认知功能 抑郁程度

2024

哈尔滨医药
哈尔滨市医学会

哈尔滨医药

影响因子:0.697
ISSN:1001-8131
年,卷(期):2024.44(1)
  • 15